Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering

Sign In \| Register \| About Pleasanton \| Contact Us
Pleasanton, CA September 01, 2020 1:32pm 7-Day Forecast \| Traffic

- American
- Asian
- Bakery
- Barbecue
- Breakfast
- Brew Pubs
- Burgers
- Cajun
- Chinese
- Coffee Houses
- Deli
- Fast Food
- Greek
- Hawaiian
- Ice Cream / Frozen Yogurt
- Indian
- Italian
- Japanese
- Korean
- Mexican
- Pizza
- Sandwiches
- Seafood
- Sports Bars
- Steaks, Chops
- Sushi
- Thai
- Vietnamese
- Apartments
- Classifieds
- Cars
- Forums
- Coupons
- News Archives
- Contests
- Free Email
- Jobs

Recent Quotes

My Watchlist

Indicators

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Photography by Christophe Tomatis

Search Hotels in Pleasanton

Find A Business

or Browse Listings

Biogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering